Stonehage Fleming (UK)’s Teva Pharmaceuticals TEVA Stock Holding History

Stonehage Fleming (UK)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$1.77M	Buy	26,992 +2,417	+10%	+$149K	0.81%	58
2015 Q3	$1.39M	Buy	24,575 +1,806	+8%	+$117K	0.66%	64
2015 Q2	$1.35M	Hold	22,769	–	–	0.61%	70
2015 Q1	$1.42M	Buy	22,769 +482	+2%	+$28K	0.66%	62
2014 Q4	$1.28M	Hold	22,287	–	–	0.63%	71
2014 Q3	$1.2M	Hold	22,287	–	–	0.53%	76
2014 Q2	$1.17M	Buy	22,287 +1,547	+7%	+$79.1K	0.47%	72
2014 Q1	$1.1M	Buy	20,740 +8,135	+65%	+$376K	0.46%	70
2013 Q4	$505K	Buy	+12,605	New	+$496K	0.2%	102

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Stonehage Fleming (UK)'s TEVA Position: Q4 2015 in Review

Stonehage Fleming (UK) increased its Teva Pharmaceuticals (TEVA) stake by 9.8% in Q4 2015, buying an estimated $149K and bringing the position to 26,992 shares worth $1.77M. The position accounts for 0.81% of the portfolio, ranked #58.

Stonehage Fleming (UK) first reported a position in TEVA in Q4 2013 and has held it in 9 quarters since. 877 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

Stonehage Fleming (UK) held 26,992 shares of Teva Pharmaceuticals worth $1.77M as of Q4 2015.
Stonehage Fleming (UK) bought 2,417 Teva Pharmaceuticals shares in Q4 2015, an estimated $149K.
Teva Pharmaceuticals made up 0.81% of Stonehage Fleming (UK)'s portfolio in Q4 2015, its #58 holding.
Stonehage Fleming (UK) first reported a position in Teva Pharmaceuticals in Q4 2013 and has held it in 9 quarters since.
877 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q4 2015, filed 11 Oct 2019.